克罗恩病回盲部切除术后并发症:REMIND组前瞻性研究
REMIND组在法国9所大学医疗中心前瞻性纳入2010年9月1日至2014年8月30日期间因克罗恩病行回盲部切除术的209例患者,术后30天并发症发生率为21%,术后无死亡。多因素分析显示术前4周内使用糖皮质激素与术后并发症发生率升高显著相关(OR=2.69,95%CI 1.15-6.29,P=0.022),而术前抗TNF治疗及血清谷浓度均非显著危险因素。
要点
- 209例克罗恩病回盲部切除患者术后30天并发症发生率为21%,无术后死亡。
- 术前4周内使用糖皮质激素与术后并发症发生率升高显著相关(OR=2.69,95%CI 1.15-6.29,P=0.022)。
- 术前抗TNF治疗(44%患者暴露)及血清谷浓度均非术后并发症的显著危险因素。
核心结论
- 在这项大型全国性前瞻性队列中,回盲部切除术后21%的患者出现术后并发症。
- 术前4周内使用糖皮质激素与术后并发症发生率升高显著相关。
- 术前抗TNF治疗(无论血清水平或末次给药与手术的时间间隔)与术后并发症风险升高无关。
研究设计与样本
- REMIND组在法国9所大学医疗中心开展全国性前瞻性研究,纳入2010年9月1日至2014年8月30日期间手术的患者。
- 前瞻性收集术前3个月的临床、生物学、手术及治疗相关数据,共纳入209例患者。
主要发现
- 回盲部切除指征为狭窄性疾病109例(52%)、穿透性并发症88例(42%)、药物难治性炎性疾病12例(6%)。
- 33例(16%)患者行二期手术;术后无死亡。
- 43例(21%)患者在中位时间5天(四分位距4-12)内共发生54次早期术后并发症:腹腔内脓毒症并发症38次、肠外感染10次、出血6次。
- 18次并发症(33%)为严重并发症(Dindo-Clavien III-IV级);14例(7%)患者需再次手术,8例(4.5%)行二次造口。
- 一期手术患者并发症发生率为23%,二期手术患者为9%(P=0.28)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We sought to determine the frequency of and risk factors for early (30-day) postoperative complications after ileocecal resection in a well-characterized, prospective cohort of Crohn's disease patients. METHODS: The REMIND group performed a nationwide study in 9 French university medical centers. Clinical-, biological-, surgical-, and treatment-related data on the 3 months before surgery were collected prospectively. Patients operated on between 1 September 2010 and 30 August 2014 were included. RESULTS: A total of 209 patients were included. The indication for ileocecal resection was stricturing disease in 109 (52%) cases, penetrating complications in 88 (42%), and medication-refractory inflammatory disease in 12 (6%). A two-stage procedure was performed in 33 (16%) patients. There were no postoperative deaths. Forty-three (21%) patients (23% of the patients with a one-stage procedure vs. 9% of those with a two-stage procedure, P=0.28) experienced a total of 54 early postoperative complications after a median time interval of 5 days (interquartile range, 4-12): intra-abdominal septic complications (n=38), extra-intestinal infections (n=10), and hemorrhage (n=6). Eighteen complications (33%) were severe (Dindo-Clavien III-IV). Reoperation was necessary in 14 (7%) patients, and secondary stomy was performed in 8 (4.5%). In a multivariate analysis, corticosteroid treatment in the 4 weeks before surgery was significantly associated with an elevated postoperative complication rate (odds ratio (95% confidence interval)=2.69 (1.15-6.29); P=0.022). Neither preoperative exposure to anti-tumor necrosis factor (TNF) agents (n=93, 44%) nor trough serum anti-TNF levels were significant risk factors for postoperative complications. CONCLUSIONS: In this large, nationwide, prospective cohort, postoperative complications were observed after 21% of the ileocecal resections. Corticosteroid treatment in the 4 weeks before surgery was significantly associated with an elevated postoperative complication rate. In contrast, preoperative anti-TNF therapy (regardless of the serum level or the time interval between last administration and surgery) was not associated with an elevated risk of postoperative complications.
引用
- Fumery M, Seksik P, Auzolle C, et al. Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group. Am J Gastroenterol. 2016. PMID: 27958285. doi:10.1038/ajg.2016.541
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。